MGTX Stock Analysis: Buy, Sell, or Hold?
MGTX - MeiraGTx Holdings plc Ordinary Shares
$11.81
0.33 (2.87%)
▲
5d:
+21.13%
30d:
+24.45%
90d:
+54.38%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When MGTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: MGTX is 16.1% above its trading range ($10.17). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: MGTX is 16.1% above its trading range ($10.17). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: MGTX is currently trading at $11.81, which is considered extended relative to its 30-day fair value range of $9.18 to $10.17.
Technical Outlook: Technically, MGTX is in a strong uptrend. The price is approaching resistance at $11.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MGTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.25 (+139.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MGTX is in a strong uptrend. The price is approaching resistance at $11.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MGTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.25 (+139.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.18 -
$10.17
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+16.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 139.2% below Wall St target ($28.25)
- WARNING: Recommendation downgraded due to 16.1% overvaluation
Trading Range Analysis
30-Day Trading Range
$9.18 -
$10.17
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$8.89
Resistance Level
$11.90
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.49
Wall Street Target
$28.25
(+139.2%)
Revenue Growth (YoY)
-84.8%
Profit Margin
-151.1%
Share & Embed Analysis
Last updated: June 24, 2026 5:20 AM ET
Data refreshes hourly during market hours. Next update: 6:20 AM
Data refreshes hourly during market hours. Next update: 6:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Richard Giroux
SELL
56000 shares
2026-04-21
Stuart Naylor
SELL
27661 shares
2026-04-07
Alexandria Forbes
SELL
62000 shares
2026-03-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 60 BUY |
